Clinical Trials Logo

NK/T-cell Lymphoma clinical trials

View clinical trials related to NK/T-cell Lymphoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04425070 Active, not recruiting - Clinical trials for Peripheral T-cell Lymphoma

A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma

TOUCH
Start date: August 18, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This trial is proposed with treatment of ATG-010 combined with chemotherapy regimens which will be chosen by investigators (ICE [ifosfamide+carboplatin+etoposide] or GEMOX [gemcitabine+oxaliplatin] or Tislelizumab), after treatments of 2 to 6 cycles transferring to ATG-010 monotherapy maintenance treatment, to evaluate the safety, tolerability, and primary efficacy of ATG-010 in R/R PTCL and NK/T-cell lymphoma patients.